Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 14Unknown 4Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1HIV Infections 1Cervical Cancer Screening 1

Interventions

Watchful Waiting 1Telemedicine 1Surveys and Questionnaires 1Radiosurgery 1Papillomavirus Vaccines 1Observation 1Motivational Interviewing 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Clinical Protocols 1Carbon-14 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Papillomavirus Infections × Papillomavirus Vaccines × Clear all
NCT05173324 2022-08-03

H2VICTORY

International Agency for Research on Cancer

Phase 3 Not yet recruiting
8,000 enrolled

HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡